211 related articles for article (PubMed ID: 14693779)
1. Assessing quality of life in Australian patients with Graves' ophthalmopathy.
Park JJ; Sullivan TJ; Mortimer RH; Wagenaar M; Perry-Keene DA
Br J Ophthalmol; 2004 Jan; 88(1):75-8. PubMed ID: 14693779
[TBL] [Abstract][Full Text] [Related]
2. Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL.
Terwee CB; Gerding MN; Dekker FW; Prummel MF; Wiersinga WM
Br J Ophthalmol; 1998 Jul; 82(7):773-9. PubMed ID: 9924370
[TBL] [Abstract][Full Text] [Related]
3. The relationship between quality of life, cognition, and thyroid status in Graves' disease.
Riguetto CM; Neto AM; Tambascia MA; Zantut-Wittmann DE
Endocrine; 2019 Jan; 63(1):87-93. PubMed ID: 30173328
[TBL] [Abstract][Full Text] [Related]
4. Test-retest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy.
Terwee CB; Gerding MN; Dekker FW; Prummel MF; van der Pol JP; Wiersinga WM
J Clin Epidemiol; 1999 Sep; 52(9):875-84. PubMed ID: 10529028
[TBL] [Abstract][Full Text] [Related]
5. Related quality of life questionnaire specific to dysthyroid ophthalmopathy evaluated in a population of patients with Graves' disease.
Delfino LC; Zunino A; Sapia V; Croome MDCS; Ilera V; Gauna AT
Arch Endocrinol Metab; 2017; 61(4):374-381. PubMed ID: 28225858
[TBL] [Abstract][Full Text] [Related]
6. Assessing Graves' ophthalmopathy-specific quality of life in Korean patients.
Choi YJ; Lim HT; Lee SJ; Lee SY; Yoon JS
Eye (Lond); 2012 Apr; 26(4):544-51. PubMed ID: 22241019
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in Graves' ophthalmopathy.
Wiersinga WM
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):359-70. PubMed ID: 22632371
[TBL] [Abstract][Full Text] [Related]
8. Assessing quality of life in Taiwanese patients with Graves' ophthalmopathy.
Lin IC; Lee CC; Liao SL
J Formos Med Assoc; 2015 Nov; 114(11):1047-54. PubMed ID: 24434244
[TBL] [Abstract][Full Text] [Related]
9. Effects of Graves' ophthalmopathy on quality of life.
Wiersinga WM; Prummel MF; Terwee CB
J Endocrinol Invest; 2004 Mar; 27(3):259-64. PubMed ID: 15165002
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of quality of life in patients with Graves´ ophthalmopathy, before and after orbital decompression.
Iacobæus L; Sahlin S
Orbit; 2016 Jun; 35(3):121-5. PubMed ID: 27159575
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument.
Gerding MN; Terwee CB; Dekker FW; Koornneef L; Prummel MF; Wiersinga WM
Thyroid; 1997 Dec; 7(6):885-9. PubMed ID: 9459632
[TBL] [Abstract][Full Text] [Related]
13. Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments.
Terwee CB; Dekker FW; Mourits MP; Gerding MN; Baldeschi L; Kalmann R; Prummel MF; Wiersinga WM
Clin Endocrinol (Oxf); 2001 Mar; 54(3):391-8. PubMed ID: 11298093
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Ophthalmic Surgery for Graves' Orbitopathy on Quality of Life: A Systematic Review and Meta-Analysis.
Woo T; Li C; Ganesananthan S; Rajendram R; Uddin J; Lee RWJ; Dayan C; Taylor P
Thyroid; 2022 Feb; 32(2):177-187. PubMed ID: 34877883
[No Abstract] [Full Text] [Related]
15. Quality of life assessment in patients with Graves' disease and progressive infiltrative ophthalmopathy during combined treatment with methylprednisolone and orbital radiotherapy.
Kulig G; Andrysiak-Mamos E; Sowińska-Przepiera E; Kulig J; Karakiewicz B; Brodowski J; Robaczyk M; Homa K; Letkiewicz M; Syrenicz A
Endokrynol Pol; 2009; 60(3):158-65. PubMed ID: 19569015
[TBL] [Abstract][Full Text] [Related]
16. Which factors are associated with quality of life in patients with Graves' orbitopathy presenting for orbital decompression surgery?
Wickwar S; McBain HB; Ezra DG; Hirani SP; Rose GE; Newman SP
Eye (Lond); 2015 Jul; 29(7):951-7. PubMed ID: 25998940
[TBL] [Abstract][Full Text] [Related]
17. Treatment choice, satisfaction and quality of life in patients with Graves' disease.
Conaglen HM; Tamatea JAU; Conaglen JV; Elston MS
Clin Endocrinol (Oxf); 2018 Jun; 88(6):977-984. PubMed ID: 29633307
[TBL] [Abstract][Full Text] [Related]
18. Measurement Properties of the Persian Translated Version of Graves Orbitopathy Quality of Life Questionnaire: A Validation Study.
Kashkouli MB; Karimi N; Aghamirsalim M; Abtahi MB; Nojomi M; Shahrad-Bejestani H; Salehi M
Ophthalmic Epidemiol; 2017 Feb; 24(1):3-10. PubMed ID: 28001456
[TBL] [Abstract][Full Text] [Related]
19. Development and psychometric properties of the Thai Graves' ophthalmopathy quality of life (GO-QOL) questionnaire.
Lumyongsatien M; Keeratidamkerngsakul B; Pornpanich K; Vangveeravong S; Saonanon P; Wiwatwongwana D; Mahaisavariya P; Aryasit O; Pongpirul K
J Patient Rep Outcomes; 2019 Dec; 4(1):1. PubMed ID: 31893319
[TBL] [Abstract][Full Text] [Related]
20. Clinical Features of Graves' Ophthalmopathy and Impact of Enalapril on the Course of Mild Graves' Ophthalmopathy: A Pilot Study.
Ataabadi G; Dabbaghmanesh MH; Owji N; Bakhshayeshkaram M; Montazeri-Najafabady N
Endocr Metab Immune Disord Drug Targets; 2020; 20(1):139-148. PubMed ID: 31345156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
